The complex role of neuroinflammation in glaucoma

Cold Spring Harbor Perspectives in Medicine

Volumn 4, Issue 8, 2014, Pages 14-

  Soto, Ileana ^a   Howell, Gareth R ^a,b  

^a JACKSON LABORATORY   (United States)

^b TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT;

ARTICLE; ASTROCYTE; CELL ACTIVATION; CELL MIGRATION; CENTRAL NERVOUS SYSTEM; GLAUCOMA; HUMAN; IMMUNE RESPONSE; MICROGLIA; NERVOUS SYSTEM INFLAMMATION; NONHUMAN; OPTIC NERVE; RETINA GANGLION CELL; TRANSENDOTHELIAL AND TRANSEPITHELIAL MIGRATION; CELL MOTION; COMPLEMENT ACTIVATION; COMPLICATION; IMMUNOLOGICAL TOLERANCE; IMMUNOLOGY; LEUKOCYTE; OPTIC NEURITIS; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; SIGNAL TRANSDUCTION;

ASTROCYTES; CELL MOVEMENT; COMPLEMENT ACTIVATION; GLAUCOMA; HUMANS; IMMUNE TOLERANCE; LEUKOCYTES; MICROGLIA; OPTIC NERVE; OPTIC NEURITIS; RETINAL GANGLION CELLS; SIGNAL TRANSDUCTION;

EID: 84928767508     PISSN: None     EISSN: 21571422     Source Type: Journal    
DOI: 10.1101/cshperspect.a017269     Document Type: Article

References (96)

1. Ahmed F, Brown KM, Stephan DA, Morrison JC, Johnson EC, Tomarev SI. 2004. Microarray analysis of changes in mRNA levels in the rat retina after experimental elevation of intraocular pressure. Invest Ophthalmol Vis Sci 45: 1247-1258.
2. Bonifati DM, Kishore U. 2007. Role of complement in neurodegeneration and neuroinflammation. Mol Immunol 44: 999-1010.
3. Bosco A, Steele MR, Vetter ML. 2011. Early microglia activation in a mouse model of chronic glaucoma. J Comp Neurol 519: 599-620.
4. Bosco A, Crish SD, Steele MR, Romero CO, Inman DM, Horner PJ, Calkins DJ, Vetter ML. 2012. Early reduction of microglia activation by irradiation in a model of chronic glaucoma. PLoS ONE 7: e43602.
5. Burgoyne CF. 2011. A biomechanical paradigm for axonal insult within the optic nerve head in aging and glaucoma. Exp Eye Res 93: 120-132.
6. Callahan MK, Ransohoff RM. 2004. Analysis of leukocyte extravasation across the blood-brain barrier: Conceptual and technical aspects. Curr Allergy Asthma Rep 4: 65-73.
7. Carson MJ, Doose JM, Melchior B, Schmid CD, Ploix CC. 2006. CNS immune privilege: Hiding in plain sight. Immunol Rev 213: 48-65.
8. Downes CE, Crack PJ. 2010. Neural injury following stroke: Are Toll-like receptors the link between the immune system and the CNS? Br J Pharmacol 160: 1872-1888.
9. Ebneter A, Casson RJ, Wood JP, Chidlow G. 2010. Microglial activation in the visual pathway in experimental glaucoma: Spatiotemporal characterization and correlation with axonal injury. Invest Ophthalmol Vis Sci 51: 6448-6460.
10. Farina C, Aloisi F, Meinl E. 2007. Astrocytes are active players in cerebral innate immunity. Trends Immunol 28: 138-145.
11. Gazi U, Martinez-Pomares L. 2009. Influence of the mannose receptor in host immune responses. Immunobiology 214: 554-561.
12. Ginhoux F, Greter M, Leboeuf M, Nandi S, See P, Gokhan S, Mehler MF, Conway SJ, Ng LG, Stanley ER, et al. 2010. Fate mapping analysis reveals that adult microglia derive from primitive macrophages. Science 330: 841-845.
13. Glass CK, Saijo K, Winner B, Marchetto MC, Gage FH. 2010. Mechanisms underlying inflammation in neurodegeneration. Cell 140: 918-934.
14. Gorina R, Santalucia T, Petegnief V, Ejarque-Ortiz A, Saura J, Planas AM. 2009. Astrocytes are very sensitive to develop innate immune responses to lipid-carried short interfering RNA. Glia 57: 93-107.
15. Gramlich OW, Beck S, Thun Hohenstein-Blaul N, Boehm N, Ziegler A, Vetter JM, Pfeiffer N, Grus FH. 2013. Enhanced insight into the autoimmune component of glaucoma: IgG autoantibody accumulation and pro-inflammatory conditions in human glaucomatous retina. PloS ONE 8: e57557.
16. Gregory MS, Hackett CG, Abernathy EF, Lee KS, Saff RR, Hohlbaum AM, Moody KS, Hobson MW, Jones A, Kolovou P, et al. 2011. Opposing roles for membrane bound and soluble Fas ligand in glaucoma-associated retinal ganglion cell death. PLoS ONE 6: e17659.
17. Hernandez MR, Andrzejewska WM, Neufeld AH. 1990. Changes in the extracellular matrix of the human optic nerve head in primary open-angle glaucoma. Am J Ophthalmol 109: 180-188.
18. Hernandez MR, Ye H, Roy S. 1994. Collagen type IV gene expression in human optic nerve heads with primary open angle glaucoma. Exp Eye Res 59: 41-51.
19. Hernandez MR, Miao H, Lukas T. 2008. Astrocytes in glaucomatous optic neuropathy. Prog Brain Res 173: 353-373.
20. Herrmann JE, Imura T, Song B, Qi J, Ao Y, Nguyen TK, Korsak RA, Takeda K, Akira S, Sofroniew MV. 2008. STAT3 is a critical regulator of astrogliosis and scar formation after spinal cord injury. J Neurosci 28: 7231-7243.
21. Howell GR, Libby RT, Jakobs TC, Smith RS, Phalan FC, Barter JW, Barbay JM, Marchant JK, Mahesh N, Porciatti V, et al. 2007. Axons of retinal ganglion cells are insulted in the optic nerve early in DBA/2J glaucoma. J Cell Biol 179: 1523-1537.
22. Howell GR, Macalinao DG, Sousa GL, Walden M, Soto I, Kneeland SC, Barbay JM, King BL, Marchant JK, Hibbs M, et al. 2011a. Molecular clustering identifies complement and endothelin induction as early events in a mouse model of glaucoma. J Clin Invest 121: 1429-1444.
23. Howell GR, Walton DO, King BL, Libby RT, John SW. 2011b. Datgan, a reusable software system for facile interrogation and visualization of complex transcription profiling data. BMC Genomics 12: 429.
24. Howell GR, Soto I, Zhu X, Ryan M, Macalinao DG, Sousa GL, Caddle LB, MacNicoll KH, Barbay JM, Porciatti V, et al. 2012. Radiation treatment inhibits monocyte entry into the optic nerve head and prevents neuronal damage in a mouse model of glaucoma. J Clin Invest 122: 1246-1261.
25. Howell GR, Soto I, Ryan M, Graham LC, Smith RS, John SW. 2013. Deficiency of complement component 5 ameliorates glaucoma in DBA/2J mice. J Neuroinflammation 10: 76.
26. Husemann J, Loike JD, Anankov R, Febbraio M, Silverstein SC. 2002. Scavenger receptors in neurobiology and neuropathology: Their role on microglia and other cells of the nervous system. Glia 40: 195-205.
27. Iadecola C, Nedergaard M. 2007. Glial regulation of the cerebral microvasculature. Nat Neurosci 10: 1369-1376.
28. Ifergan I, Kebir H, Bernard M, Wosik K, Dodelet-Devillers A, Cayrol R, Arbour N, Prat A. 2008. The blood-brain barrier induces differentiation of migrating monocytes into Th17-polarizing dendritic cells. Brain 131: 785-799.
29. Inman DM, Horner PJ. 2007. Reactive nonproliferative gliosis predominates in a chronic mouse model of glaucoma. Glia 55: 942-953.
30. Jakobs TC, Libby RT, Ben Y, John SWM, Masland RH. 2005. Retinal ganglion cell degeneration is topological but not cell type specific in DBA/2J mice. J Cell Biol 171: 313-325.
31. Janeway CA, Travers P, Walport M, Shlomchik M. 2001. Immunobiology: The Immune System in Health and Disease 5th edition. Garland Science, New York.
32. Jha P, Banda H, Tytarenko R, Bora PS, Bora NS. 2011. Complement mediated apoptosis leads to the loss of retinal ganglion cells in animal model of glaucoma. Mol Immunol 48: 2151-2158.
33. Johnson EC, Deppmeier LM, Wentzien SK, Hsu I, Morrison JC. 2000. Chronology of optic nerve head and retinal responses to elevated intraocular pressure. Invest Ophthalmol Vis Sci 41: 431-442.
34. Johnson EC, Doser TA, Cepurna WA, Dyck JA, Jia L, Guo Y, Lambert WS, Morrison JC. 2011. Cell proliferation and interleukin-6-type cytokine signaling are implicated by gene expression responses in early optic nerve head injury in rat glaucoma. Invest Ophthalmol Vis Sci 52: 504-518.
35. Johnson EC, Jia L, Cepurna WA, Doser TA, Morrison JC. 2007. Global changes in optic nerve head gene expression after exposure to elevated intraocular pressure in a rat glaucoma model. Invest Ophthalmol Vis Sci 48: 3161-3177.
36. Johnson EC, Morrison JC. 2009. Friend or foe? Resolving the impact of glial responses in glaucoma. J Glaucoma 18: 341-353.
37. Kerrigan AM, Brown GD. 2009. C-type lectins and phagocytosis. Immunobiology 214: 562-575.
38. Kompass KS, Agapova OA, Li W, Kaufman PL, Rasmussen CA, Hernandez MR. 2008. Bioinformatic and statistical analysis of the optic nerve head in a primate model of ocular hypertension. BMC Neurosci 9: 93.
39. Kono H, Rock KL. 2008. How dying cells alert the immune system to danger. Nat Rev Immunol 8: 279-289.
40. Kuehn MH, Kim CY, Ostojic J, Bellin M, Alward WL, Stone EM, Sakaguchi DS, Grozdanic SD, Kwon YH. 2006. Retinal synthesis and deposition of complement components induced by ocular hypertension. Exp Eye Res 83: 620-628.
41. Kuehn MH, Kim CY, Jiang B, Dumitrescu AV, Kwon YH. 2008. Disruption of the complement cascade delays retinal ganglion cell death following retinal ischemia-reperfusion. Exp Eye Res 87: 89-95.
42. Lampron A, Elali A, Rivest S. 2013. Innate immunity in the CNS: Redefining the relationship between the CNS and its environment. Neuron 78: 214-232.
43. Lehnardt S. 2010. Innate immunity and neuroinflammation in the CNS: The role of microglia in Toll-like receptormediated neuronal injury. Glia 58: 253-263.
44. Luo C, Yang X, Kain AD, Powell DW, Kuehn MH, Tezel G. 2010. Glaucomatous tissue stress and the regulation of immune response through glial Toll-like receptor signaling. Invest Ophthalmol Vis Sci 51: 5697-5707.
45. Lye-Barthel M, Sun D, Jakobs TC. 2013. Morphology of astrocytes in a glaucomatous optic nerve. Invest Ophthalmol Vis Sci 54: 909-917.
46. Midwood K, Sacre S, Piccinini AM, Inglis J, Trebaul A, Chan E, Drexler S, Sofat N, Kashiwagi M, Orend G, et al. 2009. Tenascin-C is an endogenous activator of Toll-like recep-tor 4 that is essential for maintaining inflammation in arthritic joint disease. Nat Med 15: 774-780.
47. Morrison JC, Dorman-Pease ME, Dunkelberger GR, Quigley HA. 1990. Optic nerve head extracellular matrix in primary optic atrophy and experimental glaucoma. Arch Ophthalmol 108: 1020-1024.
48. Nakazawa T, Nakazawa C, Matsubara A, Noda K, Hisatomi T, She H, Michaud N, Hafezi-Moghadam A, Miller JW, Benowitz LI. 2006. Tumor necrosis factor-a mediates oligodendrocyte death and delayed retinal ganglion cell loss in a mouse model of glaucoma. J Neurosci 26: 12633-12641.
49. Neufeld AH. 1999. Microglia in the optic nerve head and the region of parapapillary chorioretinal atrophy in glaucoma. Arch Ophthalmol 117: 1050-1056.
50. Nickells RW, Howell GR, Soto I, John SW. 2012. Under pressure: Cellular and molecular responses during glaucoma, a common neurodegeneration with axonopathy. Annu Rev Neurosci 35: 153-179.
51. Nikolskaya T, Nikolsky Y, Serebryiskaya T, Zvereva S, Sviridov E, Dezso Z, Rahkmatulin E, Brennan RJ, Yankovsky N, Bhattacharya SK, et al. 2009. Network analysis of human glaucomatous optic nerve head astrocytes. BMC Med Genomics 2: 24.
52. Okada S, Nakamura M, Katoh H, Miyao T, Shimazaki T, Ishii K, Yamane J, Yoshimura A, Iwamoto Y, Toyama Y, et al. 2006. Conditional ablation of Stat3 or Socs3 discloses a dual role for reactive astrocytes after spinal cord injury. Nat Med 12: 829-834.
53. Panagis L, Zhao X, Ge Y, Ren L, Mittag TW, Danias J. 2010. Gene expression changes in areas of focal loss of retinal ganglion cells in the retina of DBA/2J mice. Invest Ophthalmol Vis Sci 51: 2024-2034.
54. Pellerin L, Bouzier-Sore AK, Aubert A, Serres S, Merle M, Costalat R, Magistretti PJ. 2007. Activity-dependent regulation of energy metabolism by astrocytes: An update. Glia 55: 1251-1262.
55. Pena JD, Varela HJ, Ricard CS, Hernandez MR. 1999. Enhanced tenascin expression associated with reactive astrocytes in human optic nerve heads with primary open angle glaucoma. Exp Eye Res 68: 29-40.
56. Piccio L, Rossi B, Scarpini E, Laudanna C, Giagulli C, Issekutz AC, Vestweber D, Butcher EC, Constantin G. 2002. Molecular mechanisms involved in lymphocyte recruitment in inflamed brain microvessels: Critical roles for P-selectin glycoprotein ligand-1 and heterotrimeric Gi-linked receptors. J Immunol 168: 1940-1949.
57. Qu J, Jakobs TC. 2013. The time course of gene expression during reactive gliosis in the optic nerve. PloS ONE 8: e67094.
58. Quigley HA. 1993. Open-angle glaucoma. New Engl J Med 328: 1097-1106.
59. Quigley HA. 2011. Glaucoma. Lancet 377: 1367-1377.
60. Ransohoff RM, Brown MA. 2012. Innate immunity in the central nervous system. J Clin Invest 122: 1164-1171.
61. Ransohoff RM, Engelhardt B. 2012. The anatomical and cellular basis of immune surveillance in the central nervous system. Nat Rev Immunol 12: 623-635.
62. Ransohoff RM, Kivisakk P, Kidd G. 2003. Three or more routes for leukocyte migration into the central nervous system. Nat Rev Immunol 3: 569-581.
63. Ren L, Danias J. 2010. A role for complement in glaucoma? Adv Exp Med Biol 703: 95-104.
64. Ricklin D, Hajishengallis G, Yang K, Lambris JD. 2010. Complement: A key system for immune surveillance and homeostasis. Nat Immunol 11: 785-797.
65. Rifkin IR, Leadbetter EA, Busconi L, Viglianti G, Marshak-Rothstein A. 2005. Toll-like receptors, endogenous ligands, and systemic autoimmune disease. Immunol Rev 204: 27-42.
66. Roh M, Zhang Y, Murakami Y, Thanos A, Lee SC, Vavvas DG, Benowitz LI, Miller JW. 2012. Etanercept, a widely used inhibitor of tumor necrosis factor-a (TNF-a), prevents retinal ganglion cell loss in a rat model of glaucoma. PloS ONE 7: e40065.
67. Rosen AM, Stevens B. 2010. The role of the classical complement cascade in synapse loss during development and glaucoma. Adv Exp Med Biol 703: 75-93.
68. Rouach N, Koulakoff A, Abudara V, Willecke K, Giaume C. 2008. Astroglial metabolic networks sustain hippocampal synaptic transmission. Science 322: 1551-1555.
69. Sawada H, Fukuchi T, Tanaka T, Abe H. 2010. Tumor necrosis factor-a concentrations in the aqueous humor of patients with glaucoma. Invest Ophthalmol Vis Sci 51: 903-906.
70. Schlamp CL, Li Y, Dietz JA, Janssen KT, Nickells RW. 2006. Progressive ganglion cell loss and optic nerve degeneration in DBA/2J mice is variable and asymmetric. BMC Neurosci 7: 66.
71. Simard M, Nedergaard M. 2004. The neurobiology of glia in the context of water and ion homeostasis. Neuroscience 129: 877-896.
72. Sofroniew MV, Vinters HV. 2010. Astrocytes: Biology and pathology. Acta Neuropathol 119: 7-35.
73. Soto I, Oglesby E, Buckingham BP, Son JL, Roberson EDO, Steele MR, Inman DM, Vetter ML, Horner PJ, Marsh-Armstrong N. 2008. Retinal ganglion cells downregulate gene expression and lose their axons within the optic nerve head in a mouse glaucoma model. J Neurosci 28: 548-561.
74. Stasi K, Nagel D, Yang X, Wang RF, Ren L, Podos SM, Mittag T, Danias J. 2006. Complement component 1Q (C1Q) upregulation in retina of murine, primate, and human glaucomatous eyes. Invest Ophthalmol Vis Sci 47: 1024-1029.
75. Steele MR, Inman DM, Calkins DJ, Horner PJ, Vetter ML. 2006. Microarray analysis of retinal gene expression in the DBA/2J model of glaucoma. Invest Ophthalmol Vis Sci 47: 977-985.
76. Stevens B, Allen NJ, Vazquez LE, Howell GR, Christopherson KS, Nouri N, Micheva KD, Mehalow AK, Huberman AD, Stafford B, et al. 2007. The classical complement cascade mediates CNS synapse elimination. Cell 131: 1164-1178.
77. Sun D, Qu J, Jakobs TC. 2013. Reversible reactivity by optic nerve astrocytes. Glia 61: 1218-1235.
78. Takeuchi O, Akira S. 2010. Pattern recognition receptors and inflammation. Cell 140: 805-820.
79. Tanigami H, Okamoto T, Yasue Y, Shimaoka M. 2012. Astroglial integrins in the development and regulation of neurovascular units. Pain Res Treat 2012: 964652.
80. Taylor S, Calder CJ, Albon J, Erichsen JT, Boulton ME, Morgan JE. 2011. Involvement of the CD200 receptor complex in microglia activation in experimental glaucoma. Exp Eye Res 92: 338-343.
81. Tezel G. 2011. The immune response in glaucoma: A perspective on the roles of oxidative stress. Exp Eye Res 93: 178-186.
82. Tezel G. 2013. Immune regulation toward immunomodulation for neuroprotection in glaucoma. Curr Opin Pharmacol 13: 23-31.
83. Tezel G, Li LY, Patil RV, Wax MB. 2001. TNF-a and TNF-a receptor-1 in the retina of normal and glaucomatous eyes. Invest Ophthalmol Vis Sci 42: 1787-1794.
84. Tezel G, Yang J, Wax MB. 2004. Heat shock proteins, immunity and glaucoma. Brain Res Bull 62: 473-480.
85. Tezel G, Yang X, Luo C, Kain AD, Powell DW, Kuehn MH, Kaplan HJ. 2010. Oxidative stress and the regulation of complement activation in human glaucoma. Invest Ophthalmol Vis Sci 51: 5071-5082.
86. Tezel G, Yang X, Luo C, Cai J, Powell DW. 2012. An astrocyte-specific proteomic approach to inflammatory responses in experimental rat glaucoma. Invest Ophthalmol Vis Sci 53: 4220-4233.
87. Ullian EM, Sapperstein SK, Christopherson KS, Barres BA. 2001. Control of synapse number by glia. Science 291: 657-661.
88. Wang L, Cioffi GA, Cull G, Dong J, Fortune B. 2002. Immunohistologic evidence for retinal glial cell changes in human glaucoma. Invest Ophthalmol Vis Sci 43: 1088-1094.
89. Yan X, Tezel G, Wax MB, Edward DP. 2000. Matrix metal-loproteinases and tumor necrosis factor a in glaucomatous optic nerve head. Arch Ophthalmol 118: 666-673.
90. Yang Z, Quigley HA, Pease ME, Yang Y, Qian J, Valenta D, Zack DJ. 2007. Changes in gene expression in experimental glaucoma and optic nerve transection: The equilibrium between protective and detrimental mechanisms. Invest Ophthalmol Vis Sci 48: 5539-5548.
91. Yang X, Luo C, Cai J, Powell DW, Yu D, Kuehn MH, Tezel G. 2011. Neurodegenerative and inflammatory pathway components linked to TNF-a/TNFR1 signaling in the glaucomatous human retina. Invest Ophthalmol Vis Sci 52: 8442-8454.
92. Yuan L, Neufeld AH. 2000. Tumor necrosis factor-a: A potentially neurodestructive cytokine produced by glia in the human glaucomatous optic nerve head. Glia 32: 42-50.
93. Yuan L, Neufeld AH. 2001. Activated microglia in the human glaucomatous optic nerve head. J Neurosci Res 64: 523-532.
94. Yu L, Wang L, Chen S. 2010. Endogenous toll-like receptor ligands and their biological significance. J Cell Mol Med 14: 2592-2603.
95. Zhang Q, Raoof M, Chen Y, Sumi Y, Sursal T, Junger W, Brohi K, Itagaki K, Hauser CJ. 2010. Circulating mitochondrial DAMPs cause inflammatory responses to injury. Nature 464: 104-107.
96. Zhu H, Wang L, Ruan Y, Zhou L, Zhang D, Min Z, Xie J, Yu M, Gu J. 2011. An efficient delivery of DAMPs on the cell surface by the unconventional secretion pathway. Biochem Biophys Res Commun 404: 790-795.